Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Meinert

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Controlled Clinical Trials|December 1, 1984
Content of reports on clinical trials: a critical reviewC L Meinert, S Tonascia, K Higgins
Controlled Clinical Trials|February 1, 1990
Identification of meta-analyses. The need for standard terminologyK Dickersin, K Higgins, C L Meinert
JAMA|January 15, 1992
Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boardsK Dickersin, Y I Min, C L Meinert
Controlled Clinical Trials|September 1, 1981
On the detection of outlier clinics in medical and surgical trials: I. Practical considerationsP L Canner, Y B Huang, C L Meinert
Controlled Clinical Trials|February 13, 2001
Patient notification and follow-up after suspension of treatment protocols. experience from four clinical trials of treatments for AIDS-related CMV retinitisJ T Holbrook, C L Meinert, D A Jabs, et al.
Controlled Clinical Trials|December 1, 1983
The Coronary Drug Project. Role and methods of the Coordinating CenterC L Meinert, E C Heinz, S A Forman
Controlled Clinical Trials|September 1, 1989
Design, methods, and rationale in the Hypertension Prevention Trial. Hypertension Prevention Trial Research GroupC L Meinert, N O Borhani, H G Langford
Controlled Clinical Trials|September 1, 1981
On the detection of outlier clinics in medical and surgical trials: II. Theoretical considerationsP L Canner, Y B Huang, C L Meinert
Pediatrics|August 1, 1989
Retrospective and prospective identification of unpublished controlled trials: lessons from a survey of obstetricians and pediatriciansJ Hetherington, K Dickersin, I Chalmers, et al.
Controlled Clinical Trials|October 6, 2000
Gender representation in trialsC L Meinert, A K Gilpin, A Unalp, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Controlled Clinical Trials|December 1, 1984
Content of reports on clinical trials: a critical reviewC L Meinert, S Tonascia, K Higgins
Controlled Clinical Trials|February 1, 1990
Identification of meta-analyses. The need for standard terminologyK Dickersin, K Higgins, C L Meinert
JAMA|January 15, 1992
Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boardsK Dickersin, Y I Min, C L Meinert
Controlled Clinical Trials|September 1, 1981
On the detection of outlier clinics in medical and surgical trials: I. Practical considerationsP L Canner, Y B Huang, C L Meinert
Controlled Clinical Trials|February 13, 2001
Patient notification and follow-up after suspension of treatment protocols. experience from four clinical trials of treatments for AIDS-related CMV retinitisJ T Holbrook, C L Meinert, D A Jabs, et al.
Controlled Clinical Trials|December 1, 1983
The Coronary Drug Project. Role and methods of the Coordinating CenterC L Meinert, E C Heinz, S A Forman
Controlled Clinical Trials|September 1, 1989
Design, methods, and rationale in the Hypertension Prevention Trial. Hypertension Prevention Trial Research GroupC L Meinert, N O Borhani, H G Langford
Controlled Clinical Trials|September 1, 1981
On the detection of outlier clinics in medical and surgical trials: II. Theoretical considerationsP L Canner, Y B Huang, C L Meinert
Pediatrics|August 1, 1989
Retrospective and prospective identification of unpublished controlled trials: lessons from a survey of obstetricians and pediatriciansJ Hetherington, K Dickersin, I Chalmers, et al.
Controlled Clinical Trials|October 6, 2000
Gender representation in trialsC L Meinert, A K Gilpin, A Unalp, et al.
Pageof 6